AptaBio's Series C Round

AptaBio raised a round of funding on May 16, 2018.

AptaBio (압타바이오) is a South Korean pharmaceutical company focused on the discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs.…

Articles about AptaBio's Series C Round: